2seventy bio Overview
Valuation check: TSVT's ROE is -1.91%, below the sector sector average of 11.64%.
Get informed when a big investor buys or sells
+ Follow-1.91%
Return on Equity measures how efficiently a company uses shareholders' equity to generate profits. A higher ROE indicates better profitability relative to equity.
2seventy bio (TSVT) currently reports a ROE of -1.91%. That is below the sector sector average of 11.64%. Use the charts on this page to explore 2seventy bio's ROE history and peer comparisons.
2seventy bio's ROE of -1.91% is lower than the its sector sector average of 11.64%. That is roughly 116.4% below the sector mean. A reading lower peers can reflect different growth expectations, capital structure, or profitability — so it is worth checking the peer comparison chart before drawing conclusions.
There is no universal 'good' ROE, but 2seventy bio's current -1.91% should be judged against industry norms (sector average: 11.64%) and against TSVT's own history. Strong, stable readings often indicate durable competitive advantage; volatile or declining ones deserve a closer look at margins and capital efficiency.
Start with the current ROE of -1.91%, then check the historical chart for trend and the peer comparison chart for relative positioning. The sector average is 11.64%. From there, open related valuation or income-statement pages for 2seventy bio, and consider following TSVT for alerts when major investors trade the stock.
